HomeSectorLife SciencesUK: OrganOx completes US$142m financing to accelerate growth

UK: OrganOx completes US$142m financing to accelerate growth

-

ofinaOrganOx, a commercial stage organ technology company spun out of the University of Oxford in 2008, has completed a US$142m primary and secondary equity financing to accelerate growth opportunities for…

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Advertisement

Related Resources

Related Events